WEBULL

Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus

Simply Wall St · 1d ago

Founder led companies can be especially interesting when inflation is easing but energy and rate risks still influence market sentiment, because many founders tend to stay focused on long term execution regardless of short term noise. The Founder Led Companies screener is built to surface leaders who are personally invested in the outcome of their business and whose incentives are closely aligned with shareholders. In the sections ahead, you will see 3 stocks from this screener that stand out on quality, resilience and leadership focus, so you can judge whether any fit your own watchlist and risk appetite.

Flight Centre Travel Group (ASX:FLT)

Overview: Flight Centre Travel Group is a global travel retailer and corporate travel provider, offering leisure, corporate, and specialist travel services across Australia, New Zealand, the Americas, Europe, the Middle East, Africa, Asia, and other international markets under the Flight Centre and complementary brands.

Operations: Flight Centre Travel Group currently generates A$1.45b from Leisure, A$1.18b from Corporate and A$238.6m from Global HQ activities, with Australia & New Zealand contributing A$1.53b of revenue, followed by the Americas at A$509.2m and EMEA at A$492.9m.

Market Cap: A$2.49b

Investors may want Flight Centre Travel Group on their radar because it combines a founder led culture, seasoned management and board, and a clear push into higher value corporate, luxury and cruise travel, supported by heavy digital and AI investment like the reimagined Sam travel assistant. Forecast earnings growth near 19.7% and a Simply Wall St fair value estimate well above the current A$12.18 share price indicate that some investors may see meaningful upside if execution stays on track. The A$200m buyback also signals confidence and could support earnings per share. At the same time, reliance on external funding, an unstable dividend record and pressure on margins as customers trade down all mean this is not a set and forget travel stock and those risks deserve close attention.

Flight Centre Travel Group’s push into higher value travel and heavy digital investment could be masking the real story. Before deciding where it belongs on your watchlist, scan the 3 key rewards and 1 important warning sign

FLT Discounted Cash Flow as at Jul 2026
FLT Discounted Cash Flow as at Jul 2026

Macquarie Technology Group (ASX:MAQ)

Overview: Macquarie Technology Group is an Australian telecoms and data infrastructure company that provides enterprise voice, network, cloud, cybersecurity, and data center services to corporate and government customers. Its offer ranges from business calling and conferencing to managed cloud, disaster recovery, colocation, and security services built for regulated and mission critical users.

Operations: Macquarie Technology Group generates A$223.9m from Cloud Services & Government, A$108.2m from Telecom, and A$83.6m from Data Centres, with inter segment eliminations of A$36.3m, and all reported revenue currently coming from Australia at A$379.4m.

Market Cap: A$1.65b

Macquarie Technology Group tends to attract attention from investors looking for founder influence in essential digital infrastructure, with recurring cloud, data center, and telecom contracts that serve Australian corporates and government. The picture is mixed, with modest forecast revenue growth of 5.8% a year set against a high P/E of 49.7x and recent earnings that declined 7.9%. Margins and ROE sit in single digits, and earnings quality is complicated by substantial non cash items. At the same time, an experienced board, refreshed governance and tight analyst agreement on upside potential point to a company that may appeal to investors who are comfortable assessing funding risk and valuation stretch in exchange for exposure to core digital services.

Macquarie Technology Group’s high P/E and recent earnings decline make the story feel stretched, yet its core digital infrastructure focus keeps interest high. Review the 2 key rewards and 2 important warning signs (2 are major!) to see what might be hiding behind those headline numbers.

ASX:MAQ P/E Ratio as at Jul 2026
ASX:MAQ P/E Ratio as at Jul 2026

Mesoblast (ASX:MSB)

Overview: Mesoblast develops regenerative medicines based on mesenchymal lineage cells, aiming to treat severe inflammatory, cardiovascular, and degenerative conditions, including pediatric and adult steroid refractory acute graft versus host disease, chronic heart failure, chronic low back pain, inflammatory bowel diseases, diabetic nephropathy, and rheumatoid arthritis, supported by multiple global partnerships with large pharmaceutical companies.

Operations: Mesoblast currently generates approximately US$65.4m from developing its cell technology platform for commercialization.

Market Cap: A$3.17b

Mesoblast attracts interest because it is trying to turn first mover cell therapy science into a real business, with Ryoncil already approved in the U.S. and revenue from severe pediatric conditions, while late stage programs in chronic low back pain and heart failure target much larger patient groups backed by regulators through RMAT designations. At the same time, Mesoblast is still loss making and heavily reliant on external borrowing, so delays in trial readouts, slower adoption, or any change in reimbursement could put pressure on cash and force tough funding choices. For investors who can tolerate clinical and funding risk, the combination of its growth profile, experienced leadership, and founder influence makes Mesoblast a high stakes candidate from this founder led screener, but the real trade offs only become clear once you look deeper into its pipeline, balance sheet, and risk profile.

Mesoblast’s push to turn first mover science into real revenue is accelerating, yet the market may not be fully pricing that balance between ambition and funding risk. Get the analyst forecasts for Mesoblast before the next twist in this story surfaces.

ASX:MSB Earnings & Revenue Growth as at Jul 2026
ASX:MSB Earnings & Revenue Growth as at Jul 2026

The 3 founder led stocks in this article are only a starting point, as the full screen uncovered 84 more companies with equally compelling founder stories and aligned incentives in the Founder-Led Companies screener. Use Simply Wall St to identify and analyze the specific catalysts, capital allocation habits, and leadership narratives that matter most to you so you can focus on your highest conviction ideas.

Take Control of Your Investment Journey

If Flight Centre Travel Group or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New ideas move fast, and the strongest breakout stories rarely stay under the radar for long. Before momentum runs away and prices start dropping, consider researching earlier-stage opportunities.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.